Cargando…
Cohort profile: King’s Health Partners bladder cancer biobank
BACKGROUND: Bladder cancer (BC) is the 9th most common cancer worldwide, but little progress has been made in improving patient outcomes over the last 25 years. The King’s Health Partners (KHP) BC biobank was established to study unanswered, clinically relevant BC research questions. Donors are recr...
Autores principales: | Kotecha, Pinky, Moss, Charlotte L., Enting, Deborah, Gillett, Cheryl, Joseph, Magdalene, Josephs, Debra, Rudman, Sarah, Hughes, Simon, Cahill, Fidelma, Wylie, Harriet, Haire, Anna, Rosekilly, James, Khan, Muhammad Shamin, Nair, Rajesh, Thurairaja, Ramesh, Malde, Sachin, Van Hemelrijck, Mieke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519499/ https://www.ncbi.nlm.nih.gov/pubmed/32977748 http://dx.doi.org/10.1186/s12885-020-07437-5 |
Ejemplares similares
-
King’s Health Partners’ Prostate Cancer Biobank (KHP PCaBB)
por: Saifuddin, S. R., et al.
Publicado: (2017) -
Guy’s cancer cohort – real world evidence for cancer pathways
por: Moss, C., et al.
Publicado: (2020) -
Invadopodia play a role in prostate cancer progression
por: Manuelli, Valeria, et al.
Publicado: (2022) -
Graham Roberts Study protocol: first ‘trials within cohort study’ for bladder cancer
por: Wylie, Harriet, et al.
Publicado: (2019) -
Unmet needs in sexual health in bladder cancer patients: a systematic review of the evidence
por: Bessa, Agustina, et al.
Publicado: (2020)